News & Events
News
June 6, 2022 - From
Ìý
On June 6, 2022, MP Andy Fillmore announced an investment of nearly $1.5M for 3 projects led by researchers in Nova Scotia to understand the wider health impacts of the pandemic on Canadians.Ìý
Janice Graham (Director of TRRU) and her team received $489,566 to engage with social scientists, public health experts, and members of equity-deserving groups to develop recommendations for a more equitable and supportive healthcare governance framework in post-COVID Canada. Shawn Harmon (Co-Investigator) and Ksenia Kholina (Research Fellow) represented TRRU team at the announcement event.Ìý
Ìý
Upcoming Events
No upcoming events at this timeÌý
Ìý
Ìý
Ìý
Past Events
Poster Presentation at Maritime Health Research Summit: "Public Health Governance: Emerging Themes From Community Engagements Across Canada"Ìý
On Thursday October 24th 2024, Technoscience and Regulation Research Unit research in medicine student Brianna Legere, and research assistant Ella Hunter presented on preliminary findings from Phase 2 of the Public Health Governance ProjectÌýat the Maritime Health Research Summit.Ìý
Immunization Responses in Canada: A Nation-wide Analysis of Gaps in the "System"
Ìý
OnÌýWednesday December 8th 2021,ÌýTechnoscience and Regulation Research Unit presented a symposium at the Canadian Immunization conference onÌýImmunization Responses in Canada: A Nation-wide Analysis of Gaps in the "System".Ìý
Scholarship undertaken throughout the pandemic has identified a range of gaps in Canada’s immunizationÌýgovernance landscape, some of them persisting despite long-running calls for reform (e.g., absence of patient-centred health information systems, absence of unified vaccine injury compensation scheme, closed-loopÌý
nature of decision-making, etc.). During the COVID-19 pandemic, some gaps were addressed with ad hocÌýmeasures. Presenters in this symposium will identify governance gaps, examine public health interventionsÌýagainst the unfolding epidemiological data, and query the extent to which evidence-based decision-makingÌýwas being pursued, and the extent to which Chief Medical Officers of Health and the Public Health Agency wereÌýempowered to serve their intended purposes.
Learning Objectives
•ÌýDescribe a schema for an immunization framework that reflects responsible governance, appreciating howÌý
different aspects of immunization fit into the overall schema.Ìý
•ÌýIdentify, compare, and summarize differences in leadership, interventions, and outcomes in different partsÌýof Canada, drawing on the epidemiological data available across Canada.Ìý
•ÌýExplore why different approaches were taken in different parts of Canada, again bearing in mind theÌýdemands of the concepts of responsible governance and responsible research and innovation.Ìý
•ÌýIllustrate how clearer standards and expectations can be instantiated in a legal framework to address someÌýof the shortcomings identified.Ìý
Speakers
•ÌýJanice Graham, Director, Technoscience and Regulation Research Unit
•ÌýMaya Lowe, Research Assistant, Technoscience and Regulation Research Unit
•ÌýRachel Parker, RIM Student, Technoscience and Regulation Research Unit
•ÌýKsenia Kholina, Research Fellow, Technoscience and Regulation Research Unit
Moderator
•ÌýShawn Harmon, Co-investigator, Technoscience and Regulation Research Unit
Ìý
Transparency, Power and Influence in the Pharmaceutical Industry
Ìý
OnÌýThursday November 4th,Ìýthe MacEachen Institute for Public Policy and Governance hosted a panel discussion onÌýTransparency, Power and Influence in the Pharmaceutical Industry.Ìý
Transparency in the realm of pharmaceuticals is a deeply contested policy issue. Doctors, patients, and their allies have fought for decades to make the evidence behind many prescription drugs publicly available. And while the level of transparency has improved significantly in recent years, a number of challenges remain. It's not clear, for example, whether the evidence now on offer is actually being used to make better decisions about which drugs to prescribe. Worse, there are growing concerns that the added transparency is giving cover to parallel efforts to lower regulatory standards for drug approval.
Speakers include:
- Katherine FierlbeckÌý- McCulloch Chair and Professor of Political Science at ºÚÁϳԹÏÍø
- Janice GrahamÌý- Professor of Medical Anthropology and Paediatrics (Infectious Diseases) at ºÚÁϳԹÏÍøÌýÌý
- Matthew HerderÌý- Director of the Health Law Institute at ºÚÁϳԹÏÍø
- Nav PersaudÌý- Staff Physician at St. Michael's HospitalÌýand Canada Research Chair in Health Justice at the University of Toronto
- Constance MacIntosh (chair)Ìý- Acting Scholarly Director at the MacEachen Institute
Ìý
4S Annual General MeetingÌý
Virtual conference
October 6-9, 2021
TRRU Team hosted a panel entitledÌýEvidence-based Medicine? Regulating Vaccines, Drugs and Other Health Products during COVID 19 and Beyond.ÌýThe panel is chaired by Janice Graham, Director of TRRU and Matthew Herder, TRRU Co-investigator.Ìý
Featured presentations:Ìý
A Critical Political Economy Perspective on the Health Product Regulatory Authorities’ Responses to COVID-19 PandemicÌýby Ipek Iren Vural, TRRU Research Associate
Will Psychedelic-Assisted Therapies Benefit from COVID-19? Frictions, Evidence, and the Future of Regulation of Alternative TherapiesÌýbyÌýAgnieszka Doll, TRRU Postdoctoral FellowÌý
Ìý
Psychedelics: Past, Present, Future
Webinar series
October - December 2021
TRRU andÌýÌýco-hosted a webinar series in the Fall 2021 semester.
Featured webinars:
ÌýbyÌýDr. Tehseen N Noorani (UK) on October 26, 2021Ìý
ÌýbyÌýDr. Katherine Hendy (US) on November 30, 2021
ÌýbyÌýDr. Christian Elcock (France) on December 9, 2021